- Multiple Myeloma:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Drug Policy Based On: 1 of FDA Approved Indications;NCCN Guidelines
ECOG Score Requirement in Policy: N/A
ECOG status <=2: No
Diagnosis Types: 1 of For newly diagnosed or Primary treatment of multiple myeloma;patients who have received at least one prior therapy
Concomitant Therapy Requirement: in combination with dexamethasone
|